Published in

American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 2(63), 2019

DOI: 10.1128/aac.01671-18

Links

Tools

Export citation

Search in Google Scholar

Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model

Journal article published in 2018 by Ziad Tarazi, Mojgan Sabet, Michael N. Dudley, David C. Griffith
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

Minocycline is currently approved in the United States for the treatment of infections caused by susceptible isolates of Acinetobacter spp. The objective of these studies was to determine the minocycline exposures associated with an antibacterial effect against Acinetobacter baumannii in a rat pneumonia model.